Nonalcoholic fatty liver disease (NAFLD), recently renamed as metabolic (dysfunction)-
associated fatty liver disease (MAFLD), is a complex, multifactorial disease that progresses …

Atherosclerosis is a major instigator of cardiovascular disease (CVD) and a main cause of
global morbidity and mortality. The high prevalence of CVD calls for urgent attention to …

Helicobacter pylori infection consists a high global burden affecting more than 50% of the
world's population. It is implicated, beyond substantiated local gastric pathologies, ie, peptic …

Nonalcoholic fatty liver disease (NAFLD), also recently referred as metabolic (dysfunction)-
associated fatty liver disease (MAFLD), is characterized by hepatocyte steatosis in the …

Helicobacter pylori infection has been reported to be positively associated with
hypertension, although with conflicting results. In this study, the relationship between H …

Peng et al.[1] concluded that there is a causal influence of nonalcoholic fatty liver disease
(NAFLD), presently classified as metabolic dysfunction-associated fatty liver disease …

Both Helicobacter pylori (H. pylori) infection and metabolic syndrome (MetS) are highly
prevalent worldwide. The emergence of relevant research suggesting a pathogenic linkage …

Objective The association between Helicobacter pylori and hypertension is unclear. Herein,
we aimed to investigate the association between H. pylori and hypertension among adults in …

Background In addition to established risk factors for atherosclerotic cardiovascular
diseases (aCVDs), infections and autoimmune diseases, such as Helicobacter pylori (H …

Abstract Helicobacter pylori (Hp) Gram-negative bacteria cause gastritis or gastric ulcers.
They may be involved in the development of systemic diseases ie coronary heart disease …